TY - JOUR T1 - Correction: Quantitative systems pharmacology model predictions for efficacy of atezolizumab and nab-paclitaxel in triple-negative breast cancer JF - Journal for ImmunoTherapy of Cancer JO - J Immunother Cancer DO - 10.1136/jitc-2020-002100corr1 VL - 9 IS - 10 SP - e002100corr1 A2 - , Y1 - 2021/10/01 UR - http://jitc.bmj.com/content/9/10/e002100corr1.abstract ER -